Researchers Find Better Method to Measure and Treat AML
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML).
Read MorePosted by Clinical Lab Products | Sep 11, 2012 | Cancer, Miscellaneous |
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML).
Read MorePosted by Clinical Lab Products | Jul 9, 2012 | Cancer, Miscellaneous |
With a steep drop in the costs of sequencing and an explosion of research on genes, medical experts expect that genetic analyses of cancers will become routine.
Read MorePosted by Clinical Lab Products | Mar 5, 2012 | Molecular Diagnostics |
An interview with Mara Aspinall, president of Ventana Medical Systems Inc
Read MorePosted by Clinical Lab Products | Feb 5, 2012 | Cancer, Miscellaneous |
Judy O’Rourke We’re faced with headlines numbingly rife with dismal economic news, but a new report gives our industry good news to mull. The report, from the nonprofit Battelle Memorial Institute, Columbus, Ohio, says genetic and gen
Read MorePosted by Clinical Lab Products | Feb 1, 2012 | Cancer, Computing Systems, Information Technology, Middleware & Software, Pancreatic |
Changing the role of informatics in personalized medicine
Read More